Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-23 Purchase | 2022-11-28 4:03 pm | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 3,600 | $6.85 | $24,660 | 3,600 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-04 Option Award | 2024-06-06 4:29 pm | N/A 2034-06-03 | CARGO Therapeutics Inc. | CRGX | Lubner David Charles Director | 23,742 | $0 | 23,742 (Direct) | View |
| 2024-05-28 Option Award | 2024-06-06 4:15 pm | N/A 2034-05-28 | Arcellx Inc. | ACLX | Lubner David Charles Director | 8,011 | $0 | 8,011 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 4:10 pm | N/A 2034-05-22 | Vor Biopharma Inc. | VOR | Lubner David Charles Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 5:10 pm | N/A 2034-05-21 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 25,133 | $0 | 25,133 (Direct) | View |
| 2023-12-26 Equity Swap | 2023-12-27 5:37 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 35,400 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:37 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 98,963 | $0 | 0 (Direct) | View |
| 2023-11-09 Option Award | 2023-11-13 6:49 pm | N/A 2033-11-08 | CARGO Therapeutics Inc. | CRGX | Lubner David Charles Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2023-11-09 5:07 pm | N/A 2033-08-29 | CARGO Therapeutics Inc. | CRGX | Lubner David Charles Director | 0 | $0 | 27,637 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:17 pm | N/A 2033-06-14 | Arcellx Inc. | ACLX | Lubner David Charles Director | 11,459 | $0 | 11,459 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:35 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2023-05-26 Option Award | 2023-06-02 4:36 pm | N/A 2033-05-25 | Vor Biopharma Inc. | VOR | Lubner David Charles Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 6:37 pm | N/A 2033-05-23 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 24,900 | $0 | 24,900 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 6:21 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 7,222 | $0 | 7,222 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 5:05 pm | N/A 2032-06-13 | Vor Biopharma Inc. | VOR | Lubner David Charles Director | 16,911 | $0 | 16,911 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-06 4:07 pm | N/A 2032-06-02 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:04 pm | N/A 2028-06-02 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 25,614 | $0 | 25,614 (Direct) | View |
| 2021-03-12 Option Award(A) | 2022-03-09 6:15 pm | N/A 2031-03-11 | Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director | 17,529 | $0 | 17,529 (Direct) | View |
| 2021-10-04 Option Award(A) | 2022-03-09 6:13 pm | N/A N/A | Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director | 0 | $0 | 0 (Direct) | View |
| 2022-02-08 Conversion | 2022-02-09 5:52 pm | N/A N/A | Arcellx Inc. | ACLX | Lubner David Charles Director | 21,659 | $0 | 21,659 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-07 6:00 pm | N/A 2032-02-03 | Arcellx Inc. | ACLX | Lubner David Charles Director | 61,538 | $0 | 61,538 (Direct) | View |
Ownership | 2022-02-03 5:29 pm | N/A 2030-08-31 | Arcellx Inc. | ACLX | Lubner David Charles Director | 0 | $0 | 132,484 (Direct) | View |
| 2021-10-04 Option Award | 2021-10-06 4:15 pm | N/A 2031-10-03 | Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director | 17,245 | $0 | 17,245 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 4:38 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-27 8:37 pm | N/A 2031-05-25 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2021-02-05 Option Award | 2021-04-07 4:07 pm | N/A 2031-02-04 | Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director | 58,855 | $0 | 58,855 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-15 4:18 pm | N/A 2031-03-11 | Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2021-02-10 5:32 pm | N/A 2030-10-15 | Gemini Therapeutics Inc. | GMTX | Lubner David Charles Director | 0 | $0 | 50,338 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:13 pm | N/A 2031-02-04 | Vor Biopharma Inc. | VOR | Lubner David Charles Director | 16,900 | $0 | 16,900 (Direct) | View |
Ownership | 2021-02-04 9:47 pm | N/A 2030-08-24 | Vor Biopharma Inc. | VOR | Lubner David Charles Director | 0 | $0 | 41,196 (Direct) | View |
| 2020-09-21 Conversion | 2020-09-23 7:10 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 231,497 | $0 | 257,097 (Direct) | View |
| 2020-07-31 Option Award | 2020-09-23 7:10 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 25,600 | $0 | 257,097 (Direct) | View |
Ownership | 2020-09-16 8:53 pm | N/A 2030-03-18 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 0 | $0 | 112,033 (Direct) | View |
Ownership | 2020-07-07 9:51 pm | N/A N/A | Therapeutics Acquisition Corp. | TXAC | Lubner David Charles Director | 0 | $0 | 30,000 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Lubner David Charles Executive VP and CFO | 15,622 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A 2026-03-01 | Ra Pharmaceuticals Inc. | RARX | Lubner David Charles Executive VP and CFO | 554,842 | $0 | 0 (Direct) | View |